Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency (CONFIRM-HF)
This study is currently recruiting participants.
Verified December 2012 by Vifor Inc.
Study NCT01453608   Information provided by Vifor Inc.

First Received on October 13, 2011.   Last Updated on December 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Iron Deficiency
Chronic Heart Failure
Additional conditions recognized in this trial
Anemia, Iron-Deficiency
Heart Failure
More general conditions related to this trial
Anemia
Anemia, Hypochromic
Cardiovascular Diseases
Heart Diseases
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Ferinject (ferric carboxymaltose)
Placebo (saline)
Additional drug interventions recognized in this trial
Ferric Compounds
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Vifor Inc.
ICON Clinical Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services